[1] 李小杉,肖静,高月霞. 原发性肝癌患者生存质量研究新进展. 实用肝脏病杂志,2011,14(3):236-238. [2] Lee Y S,Dutta A.The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Gen Dev,2007,21(9):1025. [3] 郝清亚,王以浪,姚登福,等. 肝癌患者血清microRNA-21水平变化. 实用肝脏病杂志,2014,17(1):68-70. [4] Neofytou K,Smyth EC,Giakoustidis A,et al.Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases,and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor. Med Oncol,2014,31(10):239-248. [5] Sampson VB,Rong NH,Han J,et al.MicroRNA let-7a down- regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res,2007,67(20):9762. [6] Shi W,Zhang Z,Yang B,et al.Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma. Medicine,2017,96(32):e7764. [7] 陈勇治,舒健,王俊,等. 肝细胞肝癌患者血清microRNAlet-7a水平的变化及意义. 中国普通外科杂志,2017,26(7):889-894. [8] Barh D,Malhotra R,Ravi B,et al.Micrornalet-7:an emerging next-generation cancer therapeutic. Curr Oncol,2010,17(1):70-80. [9] Tsang WP,Kwok TT.Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis,2008,13(10):1215. [10] Nadiminty N,Tummala R,Lou W,et al.MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. J Biol Chem,2012,287(2):1527. [11] Nadiminty N,Tummala R,Lou W,et al.MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. Plos One,2012,7(3):e32832. [12] 许文景,黄冬云,陈平,等. MicroRNA-let-7 a在肺癌患者中的表达及其抑癌机制的探讨. 中国免疫学杂志,2016,32(2):234-238. [13] Sureban SM,May R,Ramalingam S,et al.Selective blockade of DCAMKL-1 results in tumor growth arrest by a let-7a microRNA-dependent mechanism. Gastroenterology,2009,137(2):649. [14] Long XB,Sun GB,Hu S,et al.Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep,2009,22(5):1189. [15] Takamizawa J,Konishi H,Yanagisawa K,et al.Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res,2004,64(11):3753-3756. [16] Lee HY,Mohammed KA,Kaye F,et al.Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibits tumor growth in lung cancer. Int J Nanomedicine,2013,2013(Issue 1):4481-4494. [17] Ruzzo A,Graziano F,Vincenzi B,et al.High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease. Oncologist,2012,17(6):823-829. [18] Jeong HC,Kim EK,Lee JH,et al.Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Rep,2011,4(2):383. [19] Canestrari E,Ruzzo A,Vincenzi B,et al.Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR. J Clin Oncol,2011,29(suppl 15):3635-3635. [20] Suzuki E,Ooka Y,Chiba T,et al.Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma. Clin J Gastroenterol,2015,8(1):41-46. [21] Joneshall YL,Kozik A,Nakatsu C.Correction: ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease. Plos One,2015,10(3):e0119441. [22] Lu Y,Huang S,Li P,et al.Prognostic evaluation of preoperative serum C-reactive protein concentration in patients with epithelial ovarian cancer. Exp Ther Med,2015,9(5):2003-2007. |